Photo of Brendan Prideaux

Brendan Prideaux, PhD

  • 1133 Citations
  • 16 h-Index
20052021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Brendan Prideaux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Mass spectrometry Chemical Compounds
Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Imaging techniques Chemical Compounds
Mass Spectrometry Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry Medicine & Life Sciences
Tissue Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2019 2021

Research Output 2005 2019

  • 1133 Citations
  • 16 h-Index
  • 28 Article
  • 4 Review article
  • 3 Comment/debate
  • 1 Chapter
1 Citation (Scopus)

Beyond tissue concentrations: Antifungal penetration at the site of infection

Zhao, Y., Prideaux, B., Baistrocchi, S., Sheppard, D. C. & Perlin, D. S., Apr 1 2019, In : Medical Mycology. 57, p. S161-S167

Research output: Contribution to journalReview article

Infection
Pharmaceutical Preparations
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Morbidity
Mortality

Erratum: Determination of [11C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging (Antimicrobial Agents and Chemotherapy (2015) 59:9 (5768-5774) 10.1128/AAC.01146-15)

DeMarco, V. P., Ordonez, A. A., Klunk, M., Prideaux, B., Wang, H., Zhang, Z., Tonge, P. J., Dannals, R. F., Holt, D. P., Lee, C. K. K., Weinstein, E. A., Dartois, V., Dooley, K. E. & Jain, S. K., Jan 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 9, e01368-19.

Research output: Contribution to journalComment/debate

Open Access
Rifampin
Anti-Infective Agents
Mycobacterium tuberculosis
Positron-Emission Tomography
Names
3 Citations (Scopus)

Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations

Sarathy, J., Blanc, L., Alvarez-Cabrera, N., O’Brien, P., Dias-Freedman, I., Mina, M., Zimmerman, M., Kaya, F., Liang, H. P. H., Prideaux, B., Dietzold, J., Salgame, P., Savic, R. M., Linderman, J., Kirschner, D., Pienaar, E. & Dartois, V., May 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 5, e02516-18.

Research output: Contribution to journalArticle

Fluoroquinolones
Tuberculosis
Multidrug-Resistant Tuberculosis
Levofloxacin
Population
1 Citation (Scopus)

Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development

Beites, T., O’Brien, K., Tiwari, D., Engelhart, C. A., Walters, S., Andrews, J., Yang, H. J., Sutphen, M. L., Weiner, D. M., Dayao, E. K., Zimmerman, M., Prideaux, B., Desai, P. V., Masquelin, T., Via, L. E., Dartois, V., Boshoff, H. I., Barry, C. E., Ehrt, S. & Schnappinger, D., Dec 1 2019, In : Nature communications. 10, 1, 4970.

Research output: Contribution to journalArticle

Open Access
tuberculosis
Electron Transport Complex III
Electron Transport Complex IV
Electron Transport
Mycobacterium tuberculosis
2 Citations (Scopus)

Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease

Lee, A., Prideaux, B., Lee, M. H., Zimmerman, M., Dolgov, E., Perlin, D. S. & Zhao, Y., Jun 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 6, e00524-19.

Research output: Contribution to journalArticle

Chronic Granulomatous Disease
Aspergillosis
Tissue Distribution
Infection
Prodrugs